SCHEMBL12835804

SCHEMBL12835804

CCOC(=O)c1cn(C2CC2)c2c(OS(=O)(=O)C(F)(F)F)c(F)ncc2c1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.44
KCNH2 Q12809 4/20 0.39
TOP2A P11388 4/20 0.37
TOP2B Q02880 4/20 0.37
HPGD P15428 2/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37
KMT2A Q03164 1/20 0.37
GSK3B P49841 1/20 0.36
TDP1 Q9NUW8 2/20 0.35
ADORA1 P30542 1/20 0.35
POLB P06746 1/20 0.35
KDM4E B2RXH2 1/20 0.35
PRKD3 O94806 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ALOX15 P16050 1/20 0.35
OPRM1 P35372 1/20 0.35
CLK2 P49760 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12836611 0.88 TOP2A (0.44) KCNH2TOP2ATOP2BHPGDMEN1
SCHEMBL117416 0.85 ADRB2 (0.47) ADRB2KCNH2TOP2ATOP2BHPGD
SCHEMBL115392 0.85 ADRB2 (0.55) ADRB2KCNH2TOP2ATOP2BHPGD
SCHEMBL12836210 0.84 ADRB2 (0.42) ADRB2KCNH2TOP2ATOP2BHPGD
SCHEMBL4302223 0.83 ADRB2 (0.51) ADRB2KCNH2TOP2ATOP2BHPGD
SCHEMBL7126309 0.83 ADRB2 (0.57) ADRB2KCNH2TOP2ATOP2BHPGD
SCHEMBL12836412 0.82 ADRB2 (0.49) ADRB2KCNH2TOP2ATOP2BHPGD
SCHEMBL12836620 0.82 ADRB2 (0.50) ADRB2KCNH2TOP2ATOP2BKMT2A
SCHEMBL12836413 0.81 ADRB2 (0.48) ADRB2KCNH2TOP2ATOP2BHPGD
SCHEMBL4302235 0.81 ADRB2 (0.49) ADRB2KCNH2TOP2ATOP2BHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011031745-A1 ANTIBACTERIAL FLUOROQUINOLONE ANALOGS ACHAOGEN, INC. (US) 2011-03-17 WO disclosed